Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	163.2	121.77	247.6	232.94	172.81	238.71
Cash & Short-Term Investments	163.2	121.77	247.6	232.94	172.81	238.71
Cash Growth	46.74%	-50.82%	6.29%	34.80%	-27.61%	35.29%
Accounts Receivable	1,243	1,015	1,744	1,560	1,310	1,286
Other Receivables	83.62	42.42	46.62	53.43	36.54	20.28
Receivables	1,327	1,057	1,790	1,613	1,346	1,306
Inventory	279.53	250.78	315.08	247.33	189.03	186.79
Prepaid Expenses	-	9.89	7.57	11.35	9.56	10.25
Other Current Assets	22.37	53.16	8.25	1.86	0.76	-
Total Current Assets	1,792	1,493	2,369	2,106	1,719	1,742
Property, Plant & Equipment	262.18	271.4	297.54	321.4	306.62	224.77
Long-Term Investments	15.19	15.01	13.61	16.2	42.31	23.4
Goodwill	148.49	145.04	156.2	162.69	206.96	161.06
Other Intangible Assets	178.12	179.4	159.25	138.43	121.92	97.4
Long-Term Accounts Receivable	22.11	23.22	26.11	29.62	32.15	33.94
Long-Term Deferred Tax Assets	16.1	12.4	3.74	4.82	1.78	0.77
Other Long-Term Assets	8.62	8.36	11.85	9	6.29	5.04
Total Assets	2,442	2,148	3,037	2,789	2,437	2,289

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,792	1,486	2,357	2,079	1,662	1,616
Accrued Expenses	-	72.01	64.5	56.53	49.43	43.48
Current Portion of Long-Term Debt	-	-	-	0.91	1.15	0.39
Current Portion of Leases	21.18	25.2	21.31	26.6	22.06	20.14
Current Income Taxes Payable	3.1	7.59	6.03	6.55	6.52	4.59
Other Current Liabilities	95.23	20.84	13.66	15.65	13.42	4.3
Total Current Liabilities	1,911	1,612	2,462	2,185	1,754	1,689
Long-Term Debt	-	-	-	0.07	0.97	0.92
Long-Term Leases	155.02	158	177.16	187.59	188.6	145.37
Pension & Post-Retirement Benefits	1.43	1.46	1.41	1.88	2.01	3.75
Long-Term Deferred Tax Liabilities	7.19	7.71	12.94	16.41	19.71	17.63
Other Long-Term Liabilities	-	-	1.18	1.69	6.46	1.42
Total Liabilities	2,075	1,779	2,655	2,392	1,972	1,858

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.11	5.11	5.11	5.11	5.09	5.07
Additional Paid-In Capital	347.76	347.7	347.19	345.07	340.97	339.73
Retained Earnings	16.77	16.33	32.21	32.67	91.58	75.97
Comprehensive Income & Other	-11.68	-12.28	-16.13	-11.77	-1.93	3.61
Total Common Equity	357.96	356.85	368.38	371.08	435.7	424.37
Minority Interest	9.85	12.05	13.77	25.04	28.78	5.86
Shareholders' Equity	367.8	368.91	382.14	396.12	464.48	430.23
Total Liabilities & Equity	2,442	2,148	3,037	2,789	2,437	2,289

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	176.2	183.2	198.47	215.18	212.77	166.81
Net Cash (Debt)	-13	-61.44	49.13	17.76	-39.97	71.9
Net Cash Growth	-	-	176.64%	-	-	223.81%
Net Cash Per Share	-0.03	-0.12	0.10	0.03	-0.08	0.14
Filing Date Shares Outstanding	510.87	510.87	510.75	510.72	508.7	506.57
Total Common Shares Outstanding	510.87	510.87	510.75	510.72	508.7	506.57
Working Capital	-119.38	-118.75	-93.45	-78.39	-35.81	52.94
Book Value Per Share	0.70	0.70	0.72	0.73	0.86	0.84
Tangible Book Value	31.34	32.42	52.93	69.97	106.82	165.91
Tangible Book Value Per Share	0.06	0.06	0.10	0.14	0.21	0.33
Machinery	-	104.94	145.73	148.01	131.88	155.63
Leasehold Improvements	-	129.52	134.68	131.41	113.03	74.47

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error